Estimation of tumor microvessel density by MRI using a blood pool contrast agent

International Journal of Oncology

Volumn 35, Issue 4, 2009, Pages 797-804

  Hyodo, Fuminori ^a,b   Chandramouli, Gadisetti V R ^a   Matsumoto, Shingo ^c   Matsumoto, Ken Ichiro ^a   Mitchell, James B ^a   Krishna, Murali C ^a   Munasinghe, Jeeva P ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KYUSHU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Angiogenesis; Blood volume; Microvascular density; MRI; Sunitinib; Tumor; USPIO

Indexed keywords

SUNITINIB; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BRAIN BLOOD VOLUME; CANCER GROWTH; CAPILLARY DENSITY; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; EX VIVO STUDY; FEMALE; IMAGE ANALYSIS; IN VIVO STUDY; MICROVASCULATURE; MOUSE; NOISE REDUCTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SQUAMOUS CELL CARCINOMA; STEADY STATE; TREATMENT RESPONSE; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANGIOGENESIS INHIBITORS; ANIMALS; ARTIFACTS; BLOOD VOLUME; CARCINOMA, SQUAMOUS CELL; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; DEXTRANS; FEMALE; FERROSOFERRIC OXIDE; INDOLES; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE ANGIOGRAPHY; MICE; MICE, INBRED C3H; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; PHANTOMS, IMAGING; PREDICTIVE VALUE OF TESTS; PYRROLES; SOFT TISSUE NEOPLASMS;

EID: 70449408942     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000392     Document Type: Article

References (29)

1. Brown JM and Giaccia AJ: The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58: 1408-1416, 1998.
2. Naumov GN, Akslen LA and Folkman J: Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 5: 1779-1787, 2006. (Pubitemid 44435320)
3. Gatenby RA and Gillies RJ: Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899, 2004.
4. Matsumoto S, Hyodo F, Subramanian S, Devasahayam N, Munasinghe J, Hyodo E, Gadisetti C, Cook JA, Mitchell JB and Krishna MC: Low-field paramagnetic resonance imaging of tumor oxygenation and glycolytic activity in mice. J Clin Invest 118: 1965-1973, 2008.
5. Jain RK: Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7: 987-989, 2001.
6. Bhattacharya A, Seshadri M, Oven SD, Toth K, Vaughan MM and Rustum YM: Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs. Clin Cancer Res 14: 3926-3932, 2008.
7. Dings RP, Loren M, Heun H, McNiel E, Griffioen AW, Mayo KH and Griffin RJ: Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization. Clin Cancer Res 13: 3395-3402, 2007. (Pubitemid 46944928)
8. Corot C, Robert P, Idee JM and Port M: Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 58: 1471-1504, 2006. (Pubitemid 44820503)
9. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR and Weisskoff RM: NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 40: 793-799, 1998. (Pubitemid 28543828)
10. Enochs WS, Harsh G, Hochberg F and Weissleder R: Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 9: 228-232, 1999. (Pubitemid 29115346)
11. Gambarota G, van Laarhoven HW, Philippens M, Lok J, van der Kogel A, Punt CJ and Heerschap A: Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI. Magn Reson Imaging 24: 279-286, 2006.
12. Kiselev VG, Strecker R, Ziyeh S, Speck O and Hennig J: Vessel size imaging in humans. Magn Reson Med 53: 553-563, 2005.
13. Pathak AP, Rand SD and Schmainda KM: The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (DeltaR2*) and contrast agent (MION) dose. J Magn Reson Imaging 18: 397-403, 2003.
14. Persigehl T, Bieker R, Matuszewski L, Wall A, Kessler T, Kooijman H, Meier N, Ebert W, Berdel WE, Heindel W, Mesters RM and Bremer C: Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice. Radiology 244: 449-456, 2007. (Pubitemid 47080876)
15. Tropres I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, Lamalle L and Decorps M: Vessel size imaging. Magn Reson Med 45: 397-408, 2001.
16. Van Osch MJ, Vonken EJ, Viergever MA, van der Grond J and Bakker CJ: Measuring the arterial input function with gradient echo sequences. Magn Reson Med 49: 1067-1076, 2003.
17. Belliveau JW, Rosen BR, Kantor HL, Rzedzian RR, Kennedy DN, McKinstry RC, Vevea JM, Cohen MS, Pykett IL and Brady TJ: Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 14: 538-546, 1990. (Pubitemid 20248637)
18. Boxerman JL, Hamberg LM, Rosen BR and Weisskoff RM: MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 34: 555-566, 1995.
19. Ostergaard L, Smith DF, Vestergaard-Poulsen P, Hansen SB, Gee AD, Gjedde A and Gyldensted C: Absolute cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking: comparison with positron emission tomography values. J Cereb Blood Flow Metab 18: 425-432, 1998. (Pubitemid 28166518)
20. Gambarota G, Leenders W, Maass C, Wesseling P, van der Kogel B, van Tellingen O and Heerschap A: Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI. Br J Cancer 98: 1784-1789, 2008. (Pubitemid 351748852)
21. De Lussanet QG, Backes WH, Griffioen AW, van Engelshoven JM and Beets-Tan RG: Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice. Radiology 229: 429-438, 2003.
22. Shen T, Weissleder R, Papisov M, Bogdanov A Jr and Brady TJ: Monocrystalline iron oxide nanocompounds (MION): physico-chemical properties. Magn Reson Med 29: 599-604, 1993. (Pubitemid 23138048)
23. Jung CW and Jacobs P: Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 13: 661-674, 1995.
24. Le Duc G, van der Elst L, Colet JM, Roch A, Gillis P, Le Bas JF and Muller RN: Ultrasmall particulate iron oxides as contrast agents for magnetic resonance spectroscopy: a dose-effect study. J Magn Reson Imaging 13: 619-626, 2001. (Pubitemid 32231518)
25. Mathew NT, Meyer JS, Bell RL, Johnson PC and Neblett CR: Regional cerebral blood flow and blood volume measured with the gamma camera. Neuroradiology 4: 133-140, 1972.
26. Rostrup E, Knudsen GM, Law I, Holm S, Larsson HB and Paulson OB: The relationship between cerebral blood flow and volume in humans. Neuroimage 24: 1-11, 2005. (Pubitemid 39611020)
27. Riches AC, Sharp JG, Thomas DB and Smith SV: Blood volume determination in the mouse. J Physiol 228: 279-284, 1973.
28. Le Duc G, Peoc'h M, Remy C, Charpy O, Muller RN, Le Bas JF and Decorps M: Use of T(2)-weighted susceptibility contrast MRI for mapping the blood volume in the glioma-bearing rat brain. Magn Reson Med 42: 754-761, 1999.
29. Barbier EL, Lamalle L and Decorps M: Methodology of brain perfusion imaging. J Magn Reson Imaging 13: 496-520, 2001.